Dear [Decision Maker],

As a constituent who cares about type 1 diabetes (T1D), I'm writing to ask that you sign the letter of support for the Special Diabetes Program (SDP) being circulated in the House by Reps. DeGette and Bilirakis, Co-chairs of the Congressional Diabetes Caucus.

The SDP is a core component of the Federal government's investment in T1D research and has delivered many important breakthroughs for the T1D community. In fact, the FDA recently approved the very first disease modifying therapy for T1D that delays onset of clinical T1D in those at risk. This incredible milestone was made possible because of an SDP-funded research program focused on slowing down and preventing T1D onset. There are many more research breakthroughs yet to come from the SDP to cure, treat, and prevent T1D.

Please sign the SDP support letter, which calls on House leadership to ensure that the SDP will be renewed before it expires at the end of September. In doing so, you will help us keep Federal T1D research efforts running strong, continuing to deliver hope for millions of Americans with T1D.